Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
04/06/2011 | EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
04/06/2011 | EP1255556B1 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
04/06/2011 | CN1981869B Compound non-carrier antibacterial eye drops containing practofren and its production |
04/06/2011 | CN1762495B Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
04/06/2011 | CN102006891A Continuous cell programming devices |
04/06/2011 | CN102006889A Topical combinations comprising an antimycotic agent and an antiviral agent |
04/06/2011 | CN102006882A Treating neurodegenerative diseases with progranulin (pgrn) |
04/06/2011 | CN102006867A Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
04/06/2011 | CN102002096A Amphipathic compound using somatostatin analogue as target radical and pharmaceutics application thereof |
04/06/2011 | CN102000341A Polyethylene oxide and matrix type surfactant in suppository composition |
04/06/2011 | CN102000337A Prescription for treating foot odor |
04/06/2011 | CN102000336A Carbostyril derivatives and mood stabilizers for treating mood disorders |
04/06/2011 | CN102000335A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
04/06/2011 | CN102000334A Compound preparation for treating depression |
04/06/2011 | CN102000178A Method and plaster for treating scalds and burns through combining traditional Chinese medicine with western medicine |
04/06/2011 | CN101420989B Polymer NO donor predrug nanofiber coating for medical devices and therapy |
04/06/2011 | CN101262861B Pharmaceutical for use in prevention and/or treatment of bowel disease |
04/06/2011 | CN101152164B Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same |
04/06/2011 | CN101011575B RNA interference medicament for preventing and treating atherosclerosis |
04/05/2011 | WO2010045415A2 Topical nsaid compositions having sensate component |
04/05/2011 | US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them |
04/05/2011 | US7919588 Netrin receptors |
04/05/2011 | US7919524 Compounds, compositions and methods |
04/05/2011 | US7919477 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
04/05/2011 | US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor |
04/05/2011 | US7919329 Method for screening for agents that affect food intake |
04/05/2011 | US7919123 Composition and method for treating or preventing gastrointestinal cancer |
04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
04/05/2011 | CA2739682A1 Topical nsaid compositions having sensate component |
04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
04/05/2011 | CA2461703C Modulation of physiological processes and agents useful for same |
04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
03/31/2011 | WO2011036879A1 Transferrin liposome preparation |
03/31/2011 | WO2011036202A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit |
03/31/2011 | WO2011036047A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases |
03/31/2011 | WO2010119424A3 Composition for regulating the metabolism of lipids |
03/31/2011 | US20110077217 Selectively depolymerized galactomannan polysaccharide |
03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
03/31/2011 | CA2775039A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit |
03/31/2011 | CA2760180A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases |
03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
03/30/2011 | EP2301628A1 Methods and reagents for the treatment of immunoinflammatory disorders |
03/30/2011 | EP2301579A1 Therapeutic method for reducing angiogenesis |
03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
03/30/2011 | EP2301567A1 Selective immune down regulation (SIDR) for transplantation |
03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
03/30/2011 | EP2301563A2 HSP20 peptides |
03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
03/30/2011 | EP2301556A1 Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer |
03/30/2011 | EP2301551A1 Use of alkyl phosphocholines in combination with antitumor medicaments |
03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
03/30/2011 | EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose |
03/30/2011 | EP2301537A1 Zonisamide for the treatment of obesity |
03/30/2011 | EP2301356A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
03/30/2011 | EP2300055A1 Anticancer combination therapy including triciribine |
03/30/2011 | EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
03/30/2011 | EP2300020A2 Nutritive compositions and methods of using same |
03/30/2011 | EP2300014A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
03/30/2011 | EP2300006A1 Colon cleansing method and kit |
03/30/2011 | EP2300004A2 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
03/30/2011 | EP2300003A2 Methods for treating injury associated with exposure to an alkylating species |
03/30/2011 | EP2299991A1 A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
03/30/2011 | EP2299822A2 Method for treating neurodegenerative dysfunction |
03/30/2011 | EP2299810A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
03/30/2011 | EP2178513B1 Tableted compositions containing atazanavir |
03/30/2011 | EP1838392B1 Selenium-containing medicaments for the prevention or treatment of endothelial vascular diseases |
03/30/2011 | EP1558586B1 Inhibitors of akt activity |
03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
03/30/2011 | EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
03/30/2011 | CN101998865A Combined treatment with an EGFR kinase inhibitor and an inhibitor of C-KIT |
03/30/2011 | CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t |
03/30/2011 | CN101998859A Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
03/30/2011 | CN101998858A Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
03/30/2011 | CN101991854A Novel blood fat-lowering composition |
03/30/2011 | CN101991853A Statin magnesium-containing blood lipid lowering composition |
03/30/2011 | CN101991852A Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation |
03/30/2011 | CN101991851A Ultrasound microbubble agent for treating tumors by low-intensity focused ultrasound and preparation method thereof |
03/30/2011 | CN101991563A Tooth sensitivity treatment compositions |
03/30/2011 | CN101991562A Tooth sensitivity treatment compositions |
03/30/2011 | CN101045163B High molecular anticarcinogenic prodrug, its preparing method and use |
03/29/2011 | US7915317 substantially free of glyceryl esters of medium or long chain fatty acids; propofol red blood cell-blood plasma partition coefficient, Kp, for the composition is at least about twice the Kp obtained upon administration of a conventional propofol emulsion under the same delivery conditions |
03/29/2011 | US7915312 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation. |
03/29/2011 | US7915291 Hepatitis C virus inhibitors |
03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
03/29/2011 | US7915234 Pharmaceutically active uridine esters |
03/29/2011 | US7915232 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication |
03/29/2011 | US7915226 Methods of suppressing microglial activation |
03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
03/29/2011 | US7914831 Alpha acids, isoalpha acids, reduced isoalpha acids, tetra-hydroisoalpha acids, hexa-hydroisoalpha acids, beta acids from hops; nontoxic |
03/29/2011 | US7914823 Method and composition for the topical treatment of diabetic neuropathy |